chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.46
Sex: M
Vaccine: MMR
Symptoms: Hypophagia, Lacrimation increased, Malaise, Nasal congestion, Pyrexia
Clinical narrative: Information has been received from a consumer concerning a her approximately 12 month old son with pertinent medical history reported as none and drug reactions or allergies reported as none who on an unspecified date was vaccinated with a first dose of MMR II (lot # not reported). The vaccine was expired. The patient was to return "several weeks" later to be revaccinated but the dose was postponed since the child had an ear infection. On 29-JUN-2009 he received second dose of MMR II (lot # not reported). There was no concomitant medication. After received the second dose of vaccine the patient developed fever, rash, watery eye and watery runny nose. "He was really sick". The child was seen in the emergency room. The mother stated she was told be the emergency room "he had a viral infection" and he was discharged home with his mother. At the time on the report on 06-JUL-2009 the patient had not recovered. Follow up information has been received from a nurse and medical record concerning a 17 month old patient with pertinent medical history reported as none, drug allergies reported as none and illness at the time of vaccination report as none. On 05-JUL-2009 the patient experienced fever over 102 degrees, cough and no oral intake was taken by his mother to the Emergency Room. The patient had been afebrile and did not received any TYLENOL and his temperature was 37.4 degrees. About 7 days prior to presentation to the Emergency Room, patient received MMR II at his doctor's office. The patient had not been himself according to the mother and had had decreased appetite, however, no vomiting or diarrhea reported. Patient had no sick contacts. The patient was followed by the physician. The patient also had sudden onset of rash involving the neck and torso. That was the reason why mom got the emergency room despite the patient being afebrile. The patient was doing well and had adequate urine output. The patient presented to upset Emergency Room for evaluation and management. In the Emergency Room physical examination was performed: weight: 12.35 kilos, blood pressure: 82/palp, heart rate: 122, respiratory rate: 24, saturation: 99%, temperature: 37.4 degrees. General appearance: Well-appearing kid, not sick at all, not in acute distress. Heent: Mild nasal congestion, clear tympanic membranes, clear throat. Chest: Bilateral equal air entry clear. Heart: S1, S2 normal, no murmur. Abdomen; Soft, nontender, no hepatosplenomegaly. Pulses: 2+, well perfused. Capillary refill less than 2 seconds. Musculoskeletal: No issues. Skin: Morbilliform rash blanching over the neck and trunk, front and back. The patient was diagnosed by physician with viral syndrome. The patient was found well hydrated. The patient tolerated apple juice in the Emergency Room. The patient will be discharged home in good condition with diet regular, activity as tolerated, TYLENOL as need for fever. Follow up with the primary care physician in one day. According to the father the patient recovered on 06-JUL-2009. Additional information is not expected.
Age: 1.46
Sex: M
Vaccine: MMR
Symptoms: Rash morbilliform, Rhinorrhoea, Viral infection
Clinical narrative: Information has been received from a consumer concerning a her approximately 12 month old son with pertinent medical history reported as none and drug reactions or allergies reported as none who on an unspecified date was vaccinated with a first dose of MMR II (lot # not reported). The vaccine was expired. The patient was to return "several weeks" later to be revaccinated but the dose was postponed since the child had an ear infection. On 29-JUN-2009 he received second dose of MMR II (lot # not reported). There was no concomitant medication. After received the second dose of vaccine the patient developed fever, rash, watery eye and watery runny nose. "He was really sick". The child was seen in the emergency room. The mother stated she was told be the emergency room "he had a viral infection" and he was discharged home with his mother. At the time on the report on 06-JUL-2009 the patient had not recovered. Follow up information has been received from a nurse and medical record concerning a 17 month old patient with pertinent medical history reported as none, drug allergies reported as none and illness at the time of vaccination report as none. On 05-JUL-2009 the patient experienced fever over 102 degrees, cough and no oral intake was taken by his mother to the Emergency Room. The patient had been afebrile and did not received any TYLENOL and his temperature was 37.4 degrees. About 7 days prior to presentation to the Emergency Room, patient received MMR II at his doctor's office. The patient had not been himself according to the mother and had had decreased appetite, however, no vomiting or diarrhea reported. Patient had no sick contacts. The patient was followed by the physician. The patient also had sudden onset of rash involving the neck and torso. That was the reason why mom got the emergency room despite the patient being afebrile. The patient was doing well and had adequate urine output. The patient presented to upset Emergency Room for evaluation and management. In the Emergency Room physical examination was performed: weight: 12.35 kilos, blood pressure: 82/palp, heart rate: 122, respiratory rate: 24, saturation: 99%, temperature: 37.4 degrees. General appearance: Well-appearing kid, not sick at all, not in acute distress. Heent: Mild nasal congestion, clear tympanic membranes, clear throat. Chest: Bilateral equal air entry clear. Heart: S1, S2 normal, no murmur. Abdomen; Soft, nontender, no hepatosplenomegaly. Pulses: 2+, well perfused. Capillary refill less than 2 seconds. Musculoskeletal: No issues. Skin: Morbilliform rash blanching over the neck and trunk, front and back. The patient was diagnosed by physician with viral syndrome. The patient was found well hydrated. The patient tolerated apple juice in the Emergency Room. The patient will be discharged home in good condition with diet regular, activity as tolerated, TYLENOL as need for fever. Follow up with the primary care physician in one day. According to the father the patient recovered on 06-JUL-2009. Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test negative, Rubella antibody negative, Unevaluable event
Clinical narrative: Information has been received from an Emergency Medical Technician concerning a female patient who in 1977 was vaccinated with a dose of MMR II. It was reported that the patient had a negative titer for MMR II and received another dose of MMR II on 03-JUL-2009. The patient was seen in the office. At the time of reporting the outcome of the patient was unknown. Follow up information was received from Health Care Professional who reported that no reaction occurred. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Measles antibody positive, Unevaluable event
Clinical narrative: Information has been received from a registered nurse concerning a male who was vaccinated with one dose of MMR II. The patient had low titers for measles antibodies. The vaccine was administered at a different facility and the patient did not remember when he received it. The patient had titers test performed. The patient sought medical attention by coming to health department. Follow-up information was received reporting that they had no information regarding the patient and that he "apparently had the MMR II some time ago" (date, dose and lot # not reported). No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative, Unevaluable event
Clinical narrative: Information has been received from a medical assistant concerning a female who was vaccinated with a dose of MMR II in the past, and now has low titer for rubella. The patient sought unspecified medical attention. The patient's outcome was unknown.  Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, VARCEL
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Information has been received from a physician concerning a 5 year old female with allergy to AMOXICILLIN (hives) and allergy to sulfa who on 28-APR-2009 was vaccinated at the privet doctor's office/hospital with a second dose of VARIVAX (Merck) (Lot # 663705/0331Y), subcutaneously into the left thigh and the fifth dose of DTAP (Lot # AC20B14CB), IM into the left thigh.  Concomitant therapy included vitamins (unspecified).  On 30-APR-2009 the patient developed erythematous rash that measured 7.5cm X 12 cm at left thigh injection site.  At the time of the reporting, the outcome of the event was unknown.  No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site swelling
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with the second dose of VARIVAX (Merck) and had a severe adverse reaction as far as swelling in the arm.  The physician stated that the swelling resolved in 48 hours.  The physician could not provide the dates of when it happened, the lot number or any of the patient details.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Information has been received from a consumer concerning her son, approximately a 12 or 24 months old male who was vaccinated with MMR II (dose, route and site not reported). Subsequently the patient experienced a very high fever (105F). It was unknown if the patient sought medical attention. The outcome of fever was recovered. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Hypokinesia
Clinical narrative: Information has been received from a registered nurse concerning her 4 year old son who in October 2005, was vaccinated with MMR II. One month after receiving the vaccine the patient had lost the ability to "snap" his fingers. Prior to the vaccination, the patient was able to "snap" his fingers but after the vaccination he could not anymore. The patient had sought unspecified medical attention. The patient's losing the ability to "snap" his fingers persisted. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a 5 year old male who on an unknown date, was vaccinated with the first dose of VARIVAX (Merck) (lot# 662583/0059Y) 0.5mL. Subsequently, the patient experienced warmth and swelling at the injection site. Subsequently, the patient recovered from the warmth and swelling at the injection site. Unspecified medical attention was sought. This is one of several reports from the same source. Additional information has been requested.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site rash, Rash
Clinical narrative: Information has been received from a nurse concerning an 8 year old female who on an unknown date, was vaccinated with the second dose of VARIVAX (Merck) (lot# 662572/0045Y) 0.5mL. Subsequently, the patient developed a rash around the injection site and throughout her arm in which she received the injection. Subsequently, the patient recovered from the rash around injection site and throughout her arm. Unspecified medical attention was sought. This is one of several reports from the same source. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a 12 year old female who on an unknown date, was vaccinated with the second dose of VARIVAX (Merck) (lot# 663942/0340Y) 0.5mL. On 11-MAY-2009, the patient experienced warmth, redness and severe swelling at the injection site. Subsequently, the patient recovered from warmth, redness and severe swelling at the injection site. Unspecified medical attention was sought. This is one of several reports from the same source. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a nurse concerning a 16 year old female who on an unknown date was vaccinated with the second dose of VARIVAX (lot# 662582/0059Y) 0.5mL. Subsequently the patient experienced warmth, redness and severe swelling at the injection site. Subsequently, the patient recovered from warmth, redness and severe swelling at the injection site. Unspecified medical attention was sought. This is one of several reports from the same source. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site cellulitis, Injection site erythema, Injection site nodule, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered nurse concerning a 15 year old female who was vaccinated with VARIVAX (Merck) first at a different office. Then about 6-7 days later, she received DEPO-PROVERA at this office. Some time after the DEPO-PROVERA, the patient experienced swelling at the VARIVAX (Merck) injection site. The area was about the size of a 1/2 dollar, was red and hot. The sought medical attention by having an appointment. Follow up information has been received from the registered nurse concerning this 15 year old (also reported as 14 year old) female with no pre-existing allergies, birth defects or medical conditions who on 30-APR-2009 (also reported as 03-MAY-2009) was vaccinated subcutaneously into left arm with a first dose of VARIVAX (Merck) (lot # 662575/0045Y). On 13-MAY-2009 the patient presented to the clinic, she had nodules at the site and erythema. There were no laboratory or diagnostic studies performed. The patient was given AUGMENTIN for cellulitis. At the time of the report, the patient recovered on an unspecified date. No further information was available.
Sex: M
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a consumer concerning her son who had an unspecified allergic reaction to a tetanus shot who on an unspecified date was vaccinated with a dose of MMR II. Subsequently, the patient had a reaction to this vaccine. At the time of the report, the patient's outcome was unknown. No further information is available.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Inflammation, Oedema peripheral
Clinical narrative: Information has been received from a physician concerning a 9 year old male who was vaccinated with a second dose of VARIAX (Merck). There was no concomitant medication. On unknown date the patient's arm got swollen and inflamed all the way down to his elbow. On an unspecified date, the patient recovered. The patient sought unspecified medical attention. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male who was vaccinated with one dose of VARIVAX (Merck) at 12 months of age.  In January 2009, the patient developed shingles.  The patient sought medical attention by unknown contact.  Subsequently, the patient recovered from shingles.
Sex: M
Vaccine: MMR, TD
Symptoms: Dyspnoea, Pyrexia, Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning an adult male patient who on 02-FEB-2010 was vaccinated with the first 0.5ml dose of MMR II (lot# not reported). Concomitant therapy included "tetanus shot". On approximately 02-FEB-2010, 12 hours after the vaccination, the patient developed a vesicle like rash, high fever and difficulty breathing. It was reported that the patient was an immigrant. He called the office to seek medical attention. At the time of this report, the patient had not recovered. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a Registered Nurse concerning a patient who on 14-APR-2009 was mistakenly vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). No adverse effect was reported. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood test, Body temperature increased, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 19 year old male patient who on 11-MAR-1992 was vaccinated with the first dose of MMR II.  Subsequently on 21-DEC-1994 the patient was vaccinated with the second dose of MMR II.  On 12-DEC-2009 the patient experienced mumps.  Diagnosis was made on 14-DEC-2009.  The patient had fever of 101 degrees F and had R parotitis.  The patient's first blood work was performed on 14-DEC-2009 (no results provided).  At the time of the report the outcome of the patient was unknown.  No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 19 year old male patient who on 11-MAR-1992 was vaccinated with the first dose of MMR II.  Subsequently on 21-DEC-1994 the patient was vaccinated with the second dose of MMR II.  On 12-DEC-2009 the patient experienced mumps.  Diagnosis was made on 14-DEC-2009.  The patient had fever of 101 degrees F and had R parotitis.  The patient's first blood work was performed on 14-DEC-2009 (no results provided).  At the time of the report the outcome of the patient was unknown.  No further information is available.
Age: 3.0
Sex: M
Vaccine: MMR
Symptoms: Blood test, Body temperature normal, Mumps, Parotitis, Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning an 18 year old male patient who on 26-AUG-1992 was vaccinated with a first dose of MMR II (route and lot number not reported). On 14-OCT-2009 the patient was vaccinated with a second dose of MMR II. On 04-DEC-2009 the patient experienced and was diagnosed with mumps (thought the date diagnosed was reported as 04-DEC-2009). Other symptoms presented by the patient included left parotitis. On 04-DEC-2009 the patient had a blood work done (results not reported). The patient was afebrile. The patient's outcome was unknown. This is of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 17 year old male (reported as 19 year old at symptoms onset date) who on 11-DEC-1993 was vaccinated with the first dose of MMR II.  On 09-SEP-1996, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported).  On 10-OCT-2009 the patient experienced mumps (the date diagnosed was reported as 13-OCT-2009).  On 15-OCT-2009 a blood work test showed IgM 0.46 and IgG 3.31.  As per patient's mother, the patient's temperature was 101 degrees F and the patient had bilateral parotitis.  The patient was exposed to others patients with mumps (siblings and classmates).  This is one of other case in the same household.  At the time of the report the patient's outcome was unknown.  This is one of several reports from the same source.  No further information is available.
Age: 1.24
Sex: U
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a approximately 15 month old patient who on 07-MAY-2009 was vaccinated with the first dose of MMR II (lot # 663765/0215Y).  A couple days later the mother called and stated that the child had a rash.  The patient sought unspecified medical attention.  Additional information has been requested.
Age: 1.37
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 19 year old male who on 07-FEB-1994 was vaccinated only with a first dose of MMR II.  On 09-JAN-2010 the patient experienced mumps.  The patient was diagnosed with mumps on 11-JAN-2010.  Other symptoms presented by the patient included parotitis in both sides.  The patient was afebrile.  First blood work test performed on 11-JAN-2010 included IgM (0.28), IgG (3.81) and amylase (184).  The final outcome for mumps was not reported.  This is one of several reports form the same source.  No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase, Mumps, Parotitis, Swelling, Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 17 year old male (also reported as 16 year old ) who on 02-DEC-1993 was vaccinated with his first dose of MMR II and on 22-MAY-1997 was vaccinated with his second dose of MMR II. On 21-DEC-2009 the patient experienced mumps. The patient was diagnosed on 23-DEC-2009; the patient was reported as afebrile with left parotitis and swelling under left ear. First blood work performed on 24-DEC-2009 included IgM: < 1:10; IgG: 8.01 and serum amylase: 85. This is one of several reports received from the same source. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 17 year old male patient (also reported as 19 year old at onset date) who on 16-NOV-1993 was vaccinated with a first dose of MMR II HSA (route, site and lot number not reported). On 14-OCT-1994, the patient was vaccinated with a second dose of MMR II HSA (route, site and lot number not reported). On 29-NOV-2009, the patient experienced mumps (date diagnosed reported as 29-NOV-2009). The patient was afebrile and had left parotitis. The outcome for mumps was not reported. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Accidental exposure, Product quality issue, Skin laceration
Clinical narrative: Information has been received from a physician who cut her finger on a broken vial of MMR II (lot # 663667/0036Y).  The physician reported that it was not serious.  The physician reported that they had received a ten pack carton of MMR II, that had one crushed vial.  The physician stated that the vial was intact on the top, the flip off cap, metal crimp was intact.  It was only the bottom of the vial that was crushed.  It looked like there was a residue inside the vial, but the physician was not sure.  There were glass pieces inside the carton.  The physician cut her hand on the glass pieces.  The physician stated that there was no carton damage.  That vial was the last one in the carton, the first one from the left side, back row.  The physician stated that this had never happened before.  Product Quality Complaint was involved.  Follow-up information has been obtained from the physician stating that the vaccine was not administered to the patient and the vial was broken.  Follow-up information was received from the physician who had minor scratch.  Additional information is not expected.
Age: 17.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Body temperature normal, Dizziness, Mumps, Orchitis
Clinical narrative: Information has been received from a physician concerning a 17 year old male patient with a history of exposure to mump through a classmate who on an unspecified date was vaccinated with MMR II (route, site, dose and lot number not reported). On 02-DEC-2009 the patient experienced mumps. Mumps was diagnosed on 03-DEC-2009. The patient was afebrile, developed orchitis with jaw pain and dizziness. The patient also experienced leg pain and body ache. On 03-DEC-2009 the first blood work was performed, the results were: IgM (<1:10) : <1:10. IgG (1.10) : 2.53 and serum amylase: 122. At the time of the report, the patient's outcome was unknown. Additional information is not expected.
Age: 17.0
Sex: M
Vaccine: MMR
Symptoms: Pain, Pain in extremity, Pain in jaw
Clinical narrative: Information has been received from a physician concerning a 17 year old male patient with a history of exposure to mump through a classmate who on an unspecified date was vaccinated with MMR II (route, site, dose and lot number not reported). On 02-DEC-2009 the patient experienced mumps. Mumps was diagnosed on 03-DEC-2009. The patient was afebrile, developed orchitis with jaw pain and dizziness. The patient also experienced leg pain and body ache. On 03-DEC-2009 the first blood work was performed, the results were: IgM (<1:10) : <1:10. IgG (1.10) : 2.53 and serum amylase: 122. At the time of the report, the patient's outcome was unknown. Additional information is not expected.
Age: 1.83
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Parotitis, Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 17 year old male patient who on 26-JUL-1994 was vaccinated with a first dose of MMR II HSA (route, site, dose and lot number not reported). On 14-OCT-1994, the patient was vaccinated with a second dose of MMR II HSA (route, site, dose and lot number not reported). On 11-NOV-2009 the patient was diagnosed with mumps. The first set of blood test for IgM was negative. For IgG was 4.49 and for Serum Amylase was 184. On 10-NOV-2009 the patient experienced mumps (Though the date diagnosed was reported as 11-NOV-2009). The patient was afebrile and had parotitis. The outcome for mumps was not reported. No further information is available.
Age: 20.0
Sex: F
Vaccine: MMR
Symptoms: Influenza like illness, Parotitis, Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 20 years old female patient with penicillin allergy and no pertinent medical history who on 27-APR-2009 was vaccinated with a dose of MMR II (lot # 660209/1119X).  Concomitant therapy included tuberculin purified protein derivative (manufacturer unknown) given at the same visit.  Subsequently, about 1 week after vaccination, the patient experienced fever of 102 F, flu like symptoms and parotitis.  The patient was seen for an office visit, TYLENOL was prescribed for fever.  At the time of reporting, the patient had not recovered.  Follow-up information has been received from a registered nurse concerning the female patient with penicillin and latex allergy.  It was reported that on 27-APR-2009 at 9:00 AM, the patient received SQ in her right arm the second dose of MMR II.  Per patient on 04-MAY-2009, she developed fever and parotitis.  The final patient's outcome was unknown as the patient never returned to the office.  No further information is available.
Age: 8.0
Sex: M
Vaccine: MMR
Symptoms: Blood test, Body temperature increased, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 20 year old male who on 17-APR-1991 and 09-NOV-1998 was vaccinated with a first and second dose of MMR II respectively. On 26-DEC-2009 the patient experienced mumps. The patient had a fever of 103 F. Parotitis was on the right. The blood work was done on 28-DEC-2009 and the result was not reported. The mumps was diagnosed on 28-DEC-2009. At the time of the report, the outcome was not reported. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 15 year old male who on 30-MAY-1995 and 13-FEB-1998 was vaccinated with a first and second dose of MMR II respectively.  On 18-NOV-2009 the patient experienced mumps.  The patient was afebrile.  Parotitis was on the right.  The first blood work on 20-NOV-2009 revealed serum IgM <1:10, serum IgG 5.23, and serum amylase 76.  The mumps was diagnosed on 20-NOV-2009.  At the time of the report, the outcome was not reported.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood test, Body temperature increased, Mumps, Vaccine breakthrough infection
Clinical narrative: Information has been received from a physician concerning a 15 year old male who on 14-MAR-1995 and 19-FEB-1998 was vaccinated with a first and second dose of MMR II respectively. On 30-NOV-2009 the patient experienced mumps. The body temperature was 102 F. Parotitis was on the left. The blood work was done on 03-DEC-2009 and the result was not reported. The pumps was diagnosed on 03-DEC-2009. At the time of the report, the outcome was not reported. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Skin laceration
Clinical narrative: Information has been received from an office manager concerning a female registered nurse who is an employee in the office, who on 08-MAY-2009 lacerated her fingers of her right hand when she removed a broken vial of MMR II (Lot: 663766/0035Y) from the carton. The nurse did not have exposure to the vaccine. The nurse irrigated the lacerations, applied bandage and at the time of reporting was recovering. The office manager also reported 2 vials broken (two at the neck and one vial in the bottom) in 10 package carton, the location of the broken vials was in the middle and not in the corner of the carton. There was no damage to the carton. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a physician concerning a 14 year old male who on 15-May-1996 and 23-DEC-1999 was vaccinated with a first and second dose of MMR II respectively.  On 11-DEC-2009 the patient experienced mumps.  The patient was afebrile.  The first blood work on 15-DEC-2009 revealed serum IgM <1:10, serum IgG 9.11, and serum amylase 194.  The mumps was diagnosed on 13-DEC-2009.  At the time of the report, the outcome was not reported.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Abdominal pain upper, Blood test, Headache, Mumps
Clinical narrative: Information has been received from a physician concerning a 15 year old male who on 20-MAY-1996 and 26-JAN-1999 was vaccinated with a first and second dose of MMR II respectively. On 18-JAN-2010 the patient experienced mumps. The patient had stomachache and headache for 2 weeks. The blood work was done on 20-JAN-2010 and the result was not reported. The pumps diagnosed on 20-JAN-2010. At the time of the report, the outcome was not reported. Additional information has been requested.
Age: 64.0
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a pharmacist concerning a patient who was inadvertently received a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). This occurred at a different site (not where pharmacist works). Follow up information was received from a nurse concerning the 64 year old male was received a dose of VARIVAX (Merck) (lot # 660079/0331X) on 08-MAY-2009 after he requested the chicken pox vaccine. The nurse indicated that it was given to him because that was what the asked for. The patient had no adverse reactions. Follow-up information was received from a registered nurse who reported that on 08-MAY-2009, the male patient was vaccinated with a dose of VARIVAX (Merck) (lot # 60079/0331X), subcutaneously at 10:45 hours. The nurse reported that the patient should have been given ZOSTAVAX (Merck), and that he will be given the vaccine 28 days later. The patient had no adverse events following prior vaccination. No further information was available.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 7 year old male with no medical history or drug allergy who was vaccinated with the first (SQ. 0.5ml) and the second (SQ. 0.5ml, lot # 659939/1788U) dose of VARIVAX (Merck) on 29-MAR-2003 and 17-MAR-2008 respectively. There was no concomitant medication. In May 2009 the patient experienced chickenpox lesions after receiving his second dose of VARIVAX (Merck). The patient developed 15 to 20 lesions on his buttocks and abdomen. The patient had no fever. The patient did not have lab diagnostics studies performed. The physician saw the patient. At the time of report the patient was recovering. Follow-up information was received from the physician who reported that the male patient with no pertinent medical history and no known allergies/drug reactions was vaccinated with the second dose of VARIVAX (Merck) (lot #659939/1788U) subcutaneously in his right deltoid muscle on 17-MAR-2008. The physician reported that on 01-MAY-2009, the patient got clinical presentation of chickenpox limited to skin only (from buttocks to chest, abdomen and limbs); with itching but no systemic signs or symptoms. On 04-MAY-2009, the physician examined the patient. There were no relevant diagnostic tests and laboratory data taken and there was no illness at the time of vaccination. At the time of report, the patient had recovered. This is one of several cases from the same source. No further information is available.
Age: 11.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Antibiotic resistant Staphylococcus test negative, Blood immunoglobulin G decreased, Blood immunoglobulin M normal, Culture negative, Gram stain negative
Clinical narrative: Information has been received from a medical assistant concerning an 11 year old patient who vaccinated with a dose of VARIVAX (Merck). On an unknown date the patient broke out in a rash under the arms and face. The patient's IgM was 0.49 and IgG was 2.94. It was reported that a culture was done with unknown results. The patient's final outcome was not reported. Follow up information received on 08-MAY-2009 from the medical assistant stated that the patient was vaccinated with a first and second doses of VARIVAX (Merck). The patient broke out in rash after receiving both doses. Follow up information has been received from a medical assistant concerning a 11 year old female patient with no pertinent medical history of no known drug allergies, who on 17-APR-2009 at 3:20 pm, was vaccinated with the second dose of VARIVAX (Merck) (Lot: 659604/1743X) subcutaneously in the left deltoid and MENACTRA (Lot: a2869AA) intramuscularly in the left deltoid. On 03-MAY-2009 the patient developed rash on face and axilla, which looks like varicella. But culture was positive for measles, viral culture was negative and Varicella zoster IgM was negative. On 04-MAY-2009 at 14:13 hours the patient underwent a Minimum Inhibitory Concentration (MIC), of skin with amoxacillin/clavulanate <=4/2, ampicilin/sulbactam <=8/4, ceftriaxone 8, cefazolin <=8, clindamycin <=0.25, Levofloxacin <=0.5, trimethoprim/sulfamethoxazole <=0.5/9.5, vancomycin 1, oxacillin >2, erythromycin >4. An aerobic/anaerobic culture was conducted on skin and a gram stain showed no WBC seen, no organism seen. The anaerobic culture showed no growth after 48 hours, and the aerobic culture Methicillin resistant S. aureus, quan and heavy growth, a Varicella zoster IgG test showed 2.94 and Varicella zoster IgM test showed 0.49. Finally no virus were isolated in a viral culture from a lesion. The patient was treated then with BACTRIM (suspension) 2 teaspoon oral twice a day for 10 days and BACTROBAN (Ointment) to apply twice on lesion for 5 days. The physician stated that appeared not to be related to vaccine. On an unspecified date the patient recovered. No further information is expected.
Age: 11.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Microbiology test abnormal, Rash, Rash vesicular, Skin lesion, Varicella virus test negative
Clinical narrative: Information has been received from a medical assistant concerning an 11 year old patient who vaccinated with a dose of VARIVAX (Merck). On an unknown date the patient broke out in a rash under the arms and face. The patient's IgM was 0.49 and IgG was 2.94. It was reported that a culture was done with unknown results. The patient's final outcome was not reported. Follow up information received on 08-MAY-2009 from the medical assistant stated that the patient was vaccinated with a first and second doses of VARIVAX (Merck). The patient broke out in rash after receiving both doses. Follow up information has been received from a medical assistant concerning a 11 year old female patient with no pertinent medical history of no known drug allergies, who on 17-APR-2009 at 3:20 pm, was vaccinated with the second dose of VARIVAX (Merck) (Lot: 659604/1743X) subcutaneously in the left deltoid and MENACTRA (Lot: a2869AA) intramuscularly in the left deltoid. On 03-MAY-2009 the patient developed rash on face and axilla, which looks like varicella. But culture was positive for measles, viral culture was negative and Varicella zoster IgM was negative. On 04-MAY-2009 at 14:13 hours the patient underwent a Minimum Inhibitory Concentration (MIC), of skin with amoxacillin/clavulanate <=4/2, ampicilin/sulbactam <=8/4, ceftriaxone 8, cefazolin <=8, clindamycin <=0.25, Levofloxacin <=0.5, trimethoprim/sulfamethoxazole <=0.5/9.5, vancomycin 1, oxacillin >2, erythromycin >4. An aerobic/anaerobic culture was conducted on skin and a gram stain showed no WBC seen, no organism seen. The anaerobic culture showed no growth after 48 hours, and the aerobic culture Methicillin resistant S. aureus, quan and heavy growth, a Varicella zoster IgG test showed 2.94 and Varicella zoster IgM test showed 0.49. Finally no virus were isolated in a viral culture from a lesion. The patient was treated then with BACTRIM (suspension) 2 teaspoon oral twice a day for 10 days and BACTROBAN (Ointment) to apply twice on lesion for 5 days. The physician stated that appeared not to be related to vaccine. On an unspecified date the patient recovered. No further information is expected.
Age: 11.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Varicella virus test positive
Clinical narrative: Information has been received from a medical assistant concerning an 11 year old patient who vaccinated with a dose of VARIVAX (Merck). On an unknown date the patient broke out in a rash under the arms and face. The patient's IgM was 0.49 and IgG was 2.94. It was reported that a culture was done with unknown results. The patient's final outcome was not reported. Follow up information received on 08-MAY-2009 from the medical assistant stated that the patient was vaccinated with a first and second doses of VARIVAX (Merck). The patient broke out in rash after receiving both doses. Follow up information has been received from a medical assistant concerning a 11 year old female patient with no pertinent medical history of no known drug allergies, who on 17-APR-2009 at 3:20 pm, was vaccinated with the second dose of VARIVAX (Merck) (Lot: 659604/1743X) subcutaneously in the left deltoid and MENACTRA (Lot: a2869AA) intramuscularly in the left deltoid. On 03-MAY-2009 the patient developed rash on face and axilla, which looks like varicella. But culture was positive for measles, viral culture was negative and Varicella zoster IgM was negative. On 04-MAY-2009 at 14:13 hours the patient underwent a Minimum Inhibitory Concentration (MIC), of skin with amoxacillin/clavulanate <=4/2, ampicilin/sulbactam <=8/4, ceftriaxone 8, cefazolin <=8, clindamycin <=0.25, Levofloxacin <=0.5, trimethoprim/sulfamethoxazole <=0.5/9.5, vancomycin 1, oxacillin >2, erythromycin >4. An aerobic/anaerobic culture was conducted on skin and a gram stain showed no WBC seen, no organism seen. The anaerobic culture showed no growth after 48 hours, and the aerobic culture Methicillin resistant S. aureus, quan and heavy growth, a Varicella zoster IgG test showed 2.94 and Varicella zoster IgM test showed 0.49. Finally no virus were isolated in a viral culture from a lesion. The patient was treated then with BACTRIM (suspension) 2 teaspoon oral twice a day for 10 days and BACTROBAN (Ointment) to apply twice on lesion for 5 days. The physician stated that appeared not to be related to vaccine. On an unspecified date the patient recovered. No further information is expected.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site rash
Clinical narrative: Information has been received from a licensed practical nurse concerning a patient who was vaccinated with a dose of VARIVAX (Merck).  The patient developed rash at the injection site after receive the VARIVAX (Merck).  Follow up information received on 08-MAY-2009 from the licensed practical nurse stating that this was the patient's second dose of VARIVAX (Merck).  She did not remember the patient so she was unable to provide further information.  The LPN stated that this was over a period of time and did not believe that the other patients involved (WAES 0905USA00016 and 0905USA00489) were vaccinated with the same vaccine lot number.  This is one of three reports from the same source.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash generalised
Clinical narrative: Information has been received from a licensed practical nurse concerning a patient who was vaccinated with a dose of VARIVAX (Merck). The patient developed rash on the body after receive the VARIVAX (Merck). Follow up information received on 08-May-2009 from the licensed practical nurse stating that this was the patient's second dose of VARIVAX (Merck). She did not remember the patient so she was unable to provide further information. The LPN stated that this was over a period of time and did not believe that the other patient's involved (WAES 0905USA00016 and 0905USA00488) were vaccinated with the same vaccine lot number. This is one of three reports from the same source. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning 1 of 2 sisters (the sibling's report was reported as WAES # 0904USA04511) who was vaccinated with a first and second dose of VARIVAX (Merck). After the first dose, the patient developed recurring rash. The rash was not diagnosed. After the second dose, the patient's rash re-occurred and was diagnosed as chicken pox. The outcome was unspecified. This is one of several reports from the same source,. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning 5 patients who were intended to be administered ZOSTAVAX (Merck) were inadvertently administered VARIVAX (Merck) subcutaneously 0.5mL. No adverse symptoms reported. The physician confirmed this was human error and not product confusion. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Auricular swelling
Clinical narrative: Information has been received from a pharmacist concerning a female with allergy to "mycins" who "many years ago" was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot number not reported) and her ears swelled. Subsequently, the patient recovered from her ears swelled. The patient sought medical attention by contacting the office. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pain, Injection site scar, Injection site swelling, Injection site vesicles
Clinical narrative: Information has been received from a nurse concerning a 36 month patient who on an unspecified date was vaccinated with the second dose of VARIVAX (Merck) (lot # 664719/0804Y). On an unspecified date the patient experienced a large area of swelling and pain at the injection site and may have developed some blistering which may have scarred. It was unknown if the patient sought medical attention. The outcome was not reported. This is one of several reports from the same source. A lot check has been initiated. All attempts to obtain telephone follow-up have been unsuccessful. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Drug Evaluation and Research and was released. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site reaction, Injection site warmth
Clinical narrative: Information has been received from a licensed practical nurse concerning a 12 year old male patient who on 09-SEP-2009 was vaccinated with his second dose of VARIVAX (Merck) (Lot number was not provided).  On 10-SEP-2009 the patient was seen in the office with an injection site reaction that was 3cm by 3cm.  The area was red and warm.  No fever or open lesions.  At the time of the report, the patient had not recovered.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an approximately 12 month old male patient who was vaccinated with a dose of VARIVAX (Merck) (dose, route, and lot # not reported).  The patient was seen in the office on 09-SEP-2009 with what was diagnosed as a case of breakthrough after receiving a dose of VARIVAX (Merck).  At the time of the report, the patient had not recovered.  Additional information has been requested.
Age: 19.0
Sex: U
Vaccine: MMR
Symptoms: Measles antibody negative
Clinical narrative: Information has been received from a emergency medical technician concerning a 19 year old patient who was vaccinated with MMR II and had negative titers to measles. This is one of several reports from the same source.  Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Injection site urticaria
Clinical narrative: Information has been received from a health professional concerning a patient who on an unspecified date, was vaccinated with the first dose of MMR II, 0.5 mL. The reporter stated, that on an unknown date, "after receiving MMR II the patient experienced hives at the site the injection was given. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: DTAP, MMR
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 16 month old female patient with no previous medical history reported who on 01-APR-2009 was vaccinated with the first dose of MMR II (lot number not available) 0.5 mL SQ and concomitantly at the same time with DTaP (unspecified). On 01-APR-2009, the patient experienced redness and swelling at the site of MMR II administration. The patient also seemed to be in extreme pain during administration of the vaccine. The patient sought medical attention, saw at the practice. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Rash papular
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a single dose of MMR II.  It was reported that on an unspecified date "after receiving MMR II the patient experienced a papular rash around the trunk".  The patient called to physician.  It was reported that the patient had recovered at the time of the report.  Additional information has been requested.
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Attention deficit/hyperactivity disorder, Disturbance in attention, Dyslexia, Speech disorder developmental
Clinical narrative: Information has been received from a consumer concerning her daughter who on an unspecified date was vaccinated with MMR II. Concomitant suspect therapy included VARIVAX. The reporter stated that her daughter received all childhood vaccinations, including MMR II and VARIVAX and then, after received all the childhood vaccines, the patient had developed learning disabilities such as attention deficit / hyperactivity disorder, spelling, reading concentration, and language issues, and has signs of dyslexia. This is one of several reports received from the same source. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site urticaria
Clinical narrative: Information has been received from a physician concerning a 24 month old male who on 19-MAR-2009 was vaccinated with a dose of MMR II (lot# was not provided). The patient experienced hives at the injection site two weeks later the administration date of MMR II and VARIVAX (Merck). The patient sought unspecified medical attention. On an unspecified date the patient was recovered. Additional information has been requested.